Literature DB >> 11231378

Relaxin and renal fibrosis.

G J Becker, T D Hewitson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11231378     DOI： 10.1046/j.1523-1755.2001.0590031184.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model.

Authors:  Nadine Haase; Michaela Golic; Florian Herse; Julianna Rugor; Dominik Linz; Maria Emilia Solano; Dominik N Müller; Ralf Dechend
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

2.  Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertension.

Authors:  Dimitris P Papadopoulos; Thomas Makris; Despina Perrea; Kannelina Zerva; Costas Tsioufis; Charles Faselis; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738

3.  Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels.

Authors:  Dimitris P Papadopoulos; Iordanis Mourouzis; Charles Faselis; Despina Perrea; Thomas Makris; Costas Tsioufis; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-12       Impact factor: 3.738

4.  Sex-steroid regulation of relaxin receptor isoforms (RXFP1 & RXFP2) expression in the patellar tendon and lateral collateral ligament of female WKY rats.

Authors:  Firouzeh Dehghan; Sekaran Muniandy; Ashril Yusof; Naguib Salleh
Journal:  Int J Med Sci       Date:  2014-01-09       Impact factor: 3.738

5.  The distribution of relaxin receptors in the anterior segment of primary open-angle glaucoma patients.

Authors:  Ofira Zloto; Alon Skaat; Ido Didi Fabian; Mordechai Rosner; Hana Ziv; Ari Leshno; Shlomo Melamed
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.